A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

BACKGROUND: Hypomethylating agents (HMA), azacitidine, and decitabine are frequently used in the management of myelodysplastic syndromes (MDS). However, there are no clinical trials that have directly compared these agents. We conducted a systematic review and indirectly compared the efficacy of aza...

全面介紹

Na minha lista:
書目詳細資料
發表在:Syst Rev
Main Authors: Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145118/
https://ncbi.nlm.nih.gov/pubmed/30227896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-018-0805-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍